Cytosorbents
CTSO
#9825
Rank
ยฃ34.41 M
Marketcap
ยฃ0.55
Share price
-1.20%
Change (1 day)
-24.81%
Change (1 year)

Revenue for Cytosorbents (CTSO)

Revenue in 2025 (TTM): ยฃ27.48 Million

According to Cytosorbents's latest financial reports the company's current revenue (TTM ) is ยฃ27.1 Million. In 2024 the company made a revenue of ยฃ28.36 Million an increase over the revenue in the year 2023 that were of ยฃ24.39 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytosorbents from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ27.48 M-3.09%
2024 ยฃ28.36 M16.25%
2023 ยฃ24.39 M0.54%
2022 ยฃ24.26 M-18.33%
2021 ยฃ29.71 M2.66%
2020 ยฃ28.94 M66.72%
2019 ยฃ17.36 M8.81%
2018 ยฃ15.95 M61.14%
2017 ยฃ9.9 M48.88%
2016 ยฃ6.65 M143%
2015 ยฃ2.73 M35.5%
2014 ยฃ2.01 M305.41%
2013 ยฃ0.49 M-253.84%
2012 -ยฃ0.33 Million-1495.16%
2011 ยฃ0.02 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Meridian Bioscience
VIVO
ยฃ0.24 B 822.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
ยฃ3.03 B 11,085.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
ยฃ14.52 B 53,490.05%๐Ÿ‡บ๐Ÿ‡ธ USA